Srdjan Stankovic
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Srdjan Stankovic
The proxy statement of Acadia Pharmaceuticals Inc reports total compensation of $7,797,628 for Srdjan Stankovic in fiscal 2022, including a base salary of $755,103. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Acadia Pharmaceuticals Inc (ACAD)
Proxy statement
Start not stated–2022-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Acadia Pharmaceuticals Inc (ACAD) | — | $755,103 | $7,797,628 |
| 2021 | Acadia Pharmaceuticals Inc (ACAD) | — | $739,377 | $4,869,637 |
| 2020 | Acadia Pharmaceuticals Inc (ACAD) | — | $715,869 | $4,856,415 |
| 2019 | Acadia Pharmaceuticals Inc (ACAD) | — | $693,563 | $5,088,270 |
| 2018 | Acadia Pharmaceuticals Inc (ACAD) | — | $524,785 | $5,678,381 |
Recent activity
No call appearances or filed executive changes recorded yet.